Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acalabrutinib with R-miniCHOP in Older Adults with Untreated DLBCL
NCT05820841Phase 3Recruiting
- Sponsor
- Saarland University
- Start
- Jun 2023
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acalabrutinib tablet (Variant 1) in diffuse large B-cell lymphoma (DLBCL), sponsored by Saarland University. Started Jun 2023; status: recruiting.
02
Drugs
acalabrutinib tablet (Variant 1)
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT05820841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05820841.